company background image
ICAD

iCAD NasdaqCM:ICAD Stock Report

Last Price

US$1.67

Market Cap

US$42.5m

7D

-7.2%

1Y

-76.9%

Updated

07 Dec, 2022

Data

Company Financials +
ICAD fundamental analysis
Snowflake Score
Valuation2/6
Future Growth5/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ICAD Stock Overview

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States.

iCAD, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for iCAD
Historical stock prices
Current Share PriceUS$1.67
52 Week HighUS$7.57
52 Week LowUS$1.61
Beta1.16
1 Month Change-7.22%
3 Month Change-39.05%
1 Year Change-76.87%
3 Year Change-77.37%
5 Year Change-55.58%
Change since IPO-96.70%

Recent News & Updates

Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth?

Nov 09
Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth?

Recent updates

Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth?

Nov 09
Is iCAD (NASDAQ:ICAD) In A Good Position To Invest In Growth?

Companies Like iCAD (NASDAQ:ICAD) Are In A Position To Invest In Growth

Jun 24
Companies Like iCAD (NASDAQ:ICAD) Are In A Position To Invest In Growth

iCAD (NASDAQ:ICAD) Is In A Good Position To Deliver On Growth Plans

Feb 23
iCAD (NASDAQ:ICAD) Is In A Good Position To Deliver On Growth Plans

iCAD, Inc. (NASDAQ:ICAD) Analysts Just Cut Their EPS Forecasts Substantially

Jan 06
iCAD, Inc. (NASDAQ:ICAD) Analysts Just Cut Their EPS Forecasts Substantially

Here's Why We're Not Too Worried About iCAD's (NASDAQ:ICAD) Cash Burn Situation

Nov 11
Here's Why We're Not Too Worried About iCAD's (NASDAQ:ICAD) Cash Burn Situation

Is It Too Late To Consider Buying iCAD, Inc. (NASDAQ:ICAD)?

Jun 25
Is It Too Late To Consider Buying iCAD, Inc. (NASDAQ:ICAD)?

Is iCAD (NASDAQ:ICAD) Weighed On By Its Debt Load?

May 31
Is iCAD (NASDAQ:ICAD) Weighed On By Its Debt Load?

Is iCAD, Inc. (NASDAQ:ICAD) Trading At A 39% Discount?

May 16
Is iCAD, Inc. (NASDAQ:ICAD) Trading At A 39% Discount?

iCAD, Inc. (NASDAQ:ICAD): Is Breakeven Near?

Mar 19
iCAD, Inc. (NASDAQ:ICAD): Is Breakeven Near?

Is iCAD, Inc.'s (NASDAQ:ICAD) Shareholder Ownership Skewed Towards Insiders?

Mar 02
Is iCAD, Inc.'s (NASDAQ:ICAD) Shareholder Ownership Skewed Towards Insiders?

A Look At The Intrinsic Value Of iCAD, Inc. (NASDAQ:ICAD)

Feb 15
A Look At The Intrinsic Value Of iCAD, Inc. (NASDAQ:ICAD)

Is It Too Late To Consider Buying iCAD, Inc. (NASDAQ:ICAD)?

Jan 31
Is It Too Late To Consider Buying iCAD, Inc. (NASDAQ:ICAD)?

The iCAD (NASDAQ:ICAD) Share Price Is Up 254% And Shareholders Are Boasting About It

Jan 11
The iCAD (NASDAQ:ICAD) Share Price Is Up 254% And Shareholders Are Boasting About It

How Much Are iCAD, Inc. (NASDAQ:ICAD) Insiders Taking Off The Table?

Dec 21
How Much Are iCAD, Inc. (NASDAQ:ICAD) Insiders Taking Off The Table?

Analysts Expect Breakeven For iCAD, Inc. (NASDAQ:ICAD) Before Long

Nov 30
Analysts Expect Breakeven For iCAD, Inc. (NASDAQ:ICAD) Before Long

Shareholder Returns

ICADUS Healthcare ServicesUS Market
7D-7.2%-5.3%-3.7%
1Y-76.9%-48.7%-21.2%

Return vs Industry: ICAD underperformed the US Healthcare Services industry which returned -47.4% over the past year.

Return vs Market: ICAD underperformed the US Market which returned -20.6% over the past year.

Price Volatility

Is ICAD's price volatile compared to industry and market?
ICAD volatility
ICAD Average Weekly Movement12.9%
Healthcare Services Industry Average Movement10.6%
Market Average Movement7.4%
10% most volatile stocks in US Market15.6%
10% least volatile stocks in US Market3.3%

Stable Share Price: ICAD is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 13% a week.

Volatility Over Time: ICAD's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1984137Stacey Stevenshttps://www.icadmed.com

iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, and image storage and review systems; SecondLook, a machine learning-based cancer detection algorithm that analyzes 2D full-field digital mammography images to identify and mark suspicious masses and calcifications; and automated density assessment solutions, which provides automated, consistent, and standardized density assessment.

iCAD, Inc. Fundamentals Summary

How do iCAD's earnings and revenue compare to its market cap?
ICAD fundamental statistics
Market CapUS$42.50m
Earnings (TTM)-US$14.71m
Revenue (TTM)US$29.26m

1.5x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ICAD income statement (TTM)
RevenueUS$29.26m
Cost of RevenueUS$8.08m
Gross ProfitUS$21.18m
Other ExpensesUS$35.89m
Earnings-US$14.71m

Last Reported Earnings

Sep 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-0.58
Gross Margin72.39%
Net Profit Margin-50.26%
Debt/Equity Ratio0%

How did ICAD perform over the long term?

See historical performance and comparison